š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to assess the feasibility and safety of inject...
Status
Terminated
Location
The University of Texas health Science Center at Houston
Start Date
2024-07-16
Trial ID
NCT06374290
Treatments Being Tested
The objective of this study is to evaluate the comparative bioavailability ...
Status
Terminated
Location
California Clinical Trials
Start Date
2010-01
Trial ID
NCT01046214
Treatments Being Tested
A placebo controlled study evaluating the effectiveness of medication in pr...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-23
Trial ID
NCT00069459
Treatments Being Tested
The primary objective of this study is to evaluate the impact of substance-...
Status
Completed
Location
La Frontera
Start Date
2010-02
Trial ID
NCT01077024
Treatments Being Tested
The purpose of the study is to examine the effect of bupropion on seizure t...
Status
Completed
Location
Duke University Medical Center
Start Date
2017-08-25
Trial ID
NCT03126682
Treatments Being Tested
The purpose of this post approval pragmatic clinical study is to see how we...
Status
Completed
Location
Nutrition Research Centre
Start Date
2023-01-19
Trial ID
NCT05579249
Treatments Being Tested
This three-group randomized double-blind placebo-controlled trial (N=180) w...
Status
Completed
Location
Rose Research Center
Start Date
2021-12-14
Trial ID
NCT05205811
Treatments Being Tested
The purpose of this study is to compare the rate and extent of absorption o...
Status
Completed
Location
SFBC Ft. Myers, Inc.
Start Date
2006-03
Trial ID
NCT00865111
The purpose of this study is to demonstrate the relative bioequivalence of ...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00861939
This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Status
Completed
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Start Date
2017-05-05
Trial ID
NCT03078075
Treatments Being Tested